Jeffrey Lynn Robins serves as Executive at Nu-Med Plus, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey Lynn Robins has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 7, 2023 involved receiving (via award) 200,000 shares valued at $4.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 7, 2023 | NUMD | $4.0K | Award | 200,000 | $0.02 | Discretionary |
Jeffrey Lynn Robins currently holds 5,200,000 shares of Nu-Med Plus, Inc. (NUMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Lynn Robins has been a net neutral trader of NUMD stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey Lynn Robins's most recent insider trade was on Nov 7, 2023, when they sold 200,000 shares at $0.02 per share.
Get notified when new Form 4 filings are submitted